탁원영 프로필 사진

탁원영

Tak Wonyoung

의과대학

의학과

Web Of Science Scopus ORCID

자료 필터

자료유형

발행연도

2022 ~ 2025
2022 2025

키워드

언어

전체 61건 중 21번부터 30번까지의 결과를 표시합니다.

2024
Article

mRECIST outcomes in EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization plus durvalumab with/without bevacizumab in participants with embolization-eligible hepatocellular carcinoma

  • Sangro, Bruno ; 
  • Kudo, Masatoshi ; 
  • Erinjeri, Joseph ; 
  • Qin, Shukui ; 
  • Ren, Zhenggang ; 
  • ... Tak, Won Young ; 
  • 외 14명
  • 2024-06
  • Journal of Hepatology
  • ELSEVIER
Article

Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis

  • 2024-06
  • Journal of Hepatology
  • ELSEVIER
Article

Positive regulation of cell proliferation by the miR-1290-EHHADH axis in hepatocellular carcinoma

  • 2024-06
  • CANCER COMMUNICATIONS
  • WILEY
Article

Increased RNA Methylation of HDGF in Human Colorectal Cancer Cell Growth and Proliferation

  • 2024-03
  • Cancer Science
  • WILEY
Article

Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the Phase 3 HIMALAYA study

  • Vogel, Arndt ; 
  • Chan, Stephen L. ; 
  • Furuse, Junji ; 
  • Tak, Won Young ; 
  • Masi, Gianluca ; 
  • 외 9명
  • 2024-02
  • Oncology Research and Treatment
  • KARGER
Article

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma

  • 2024-02
  • Cancers
  • MDPI
Article

EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization.

  • Lencioni, Riccardo ; 
  • Kudo, Masatoshi ; 
  • Erinjeri, Joseph ; 
  • Qin, Shukui ; 
  • Ren, Zhenggang ; 
  • ... Tak, Won Young ; 
  • 외 14명
  • 2024-01-20
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib

  • 2024-01
  • Cancers
  • MDPI